Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



LOVE TED W Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2023 4 LOVE TED W (Director) has filed a Form 4 on Structure Therapeutics Inc.
Txns: Granted 75,000 options to buy @ $0
08/04/2023 3 LOVE TED W (Director) has filed a Form 3 on Structure Therapeutics Inc.
06/02/2023 4 LOVE TED W (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2022 4 LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 9,200 shares @ $68.15, valued at $627k
Exercised 9,444 restricted stock units @ $0
Exercised 9,109 restricted stock units @ $0
08/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2022 4 LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 10,531 shares @ $29.33, valued at $308.9k
Exercised 9,750 restricted stock units @ $0
Exercised 11,250 restricted stock units @ $0
Exercised 8,955 restricted stock units @ $0
01/06/2022 4/A LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 24,821 shares @ $3.4, valued at $84.4k
09/24/2021 4/A LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 14,853 shares @ $27.33, valued at $405.9k
Exercised 9,750 restricted stock units @ $0
Exercised 11,250 restricted stock units @ $0
Exercised 8,955 restricted stock units @ $0
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/03/2021 4 LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 14,853 shares @ $27.33, valued at $405.9k
Exercised 9,750 restricted stock units @ $0
Exercised 11,250 restricted stock units @ $0
Exercised 8,955 restricted stock units @ $0
06/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/17/2020 4 LOVE TED W (Director) has filed a Form 4 on Royalty Pharma plc
Txns: Granted 7,280 shares @ $0
08/10/2020 3 LOVE TED W (Director) has filed a Form 3 on Royalty Pharma plc
08/04/2020 4 LOVE TED W (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Gifted 306,000 shares @ $0
Paid exercise price by delivering 20,834 shares @ $67.48, valued at $1.4M
Exercised 12,062 restricted stock units @ $0
Exercised 9,750 restricted stock units @ $0
Exercised 11,250 restricted stock units @ $0
Exercised 8,955 restricted stock units @ $0
07/02/2020 4 LOVE TED W (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Disposed/sold 15,575 restricted stock units @ $18, valued at $280.4k
Disposed/sold 11,377 options to buy @ $17.94, valued at $204.1k
Disposed/sold 14,812 options to buy @ $0
06/15/2020 4 LOVE TED W (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 7,281 shares @ $0
Granted 11,377 options to buy @ $17.94, valued at $204.1k
06/08/2020 4 LOVE TED W (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 5,855 shares @ $0
Granted 18,574 options to buy @ $12.81, valued at $237.9k
06/03/2020 4 LOVE TED W (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Granted 141,400 restricted stock units @ $0
04/29/2020 4 LOVE TED W (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Sold 1,300 shares @ $81.1492, valued at $105.5k
Sold 1,517 shares @ $80.6327, valued at $122.3k
Sold 40,000 shares @ $80.004, valued at $3.2M
02/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2020 4 LOVE TED W (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Granted 579 shares @ $36.68, valued at $21.2k
Paid exercise price by delivering 14,169 shares @ $65.26, valued at $924.7k
Exercised 12,063 restricted stock units @ $0
Exercised 9,750 restricted stock units @ $0
Exercised 11,250 restricted stock units @ $0
Granted 71,640 restricted stock units @ $0
Granted 114,190 options to buy @ $65.82, valued at $7.5M
01/23/2020 4 LOVE TED W (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Sold 29,311 shares @ $81.9773, valued at $2.4M
Sold 10,166 shares @ $82.782, valued at $841.6k
Sold 523 shares @ $83.5615, valued at $43.7k
Sold 6,819 shares @ $81.0142, valued at $552.4k
Sold 32,150 shares @ $81.8538, valued at $2.6M
Sold 1,031 shares @ $82.4549, valued at $85k
12/17/2019 4 LOVE TED W (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 43,383 shares @ $76.88, valued at $3.3M
Exercised 87,500 restricted stock units @ $0
12/09/2019 4 LOVE TED W (See Remarks.) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Sold 11,287 shares @ $74.6223, valued at $842.3k
Sold 12,442 shares @ $75.3476, valued at $937.5k
Sold 996 shares @ $74.08, valued at $73.8k
Sold 8,525 shares @ $74.6602, valued at $636.5k
Sold 6,750 shares @ $75.3886, valued at $508.9k
Sold 6,332 shares @ $75.7283, valued at $479.5k
Sold 6,800 shares @ $76.7826, valued at $522.1k
Sold 23,152 shares @ $77.718, valued at $1.8M
Sold 3,716 shares @ $76.15, valued at $283k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy